Incomplete Antibody Evolution and Seroreversion after Treatment of Primary HIV Type 1 Infection: What Is the Clinical Significance?

This publication has 18 references indexed in Scilit:

• Incomplete HIV Type 1 Antibody Evolution and Seroreversion in Acutely Infected Individuals Treated with Early Antiretroviral Therapy
  Clinical Infectious Diseases, 2005
• Performance of the OraQuick Rapid Antibody Test for Diagnosis of Human Immunodeficiency Virus Type 1 Infection in Patients with Various Levels of Exposure to Highly Active Antiretroviral Therapy
  Journal of Clinical Microbiology, 2003
• Selective Increases in HIV-Specific Neutralizing Antibody and Partial Reconstitution of Cellular Immune Responses during Prolonged, Successful Drug Therapy of HIV Infection
  AIDS Research and Human Retroviruses, 2001
• Rhesus Macaques That Become Systemically Infected With Pathogenic SHIV 89.6-PD After Intravenous, Rectal, or Vaginal Inoculation and Fail to Make an Antiviral Antibody Response Rapidly Develop AIDS
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
• HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy
  Journal of Experimental Medicine, 1998
• Rapid Disease Progression without Seroconversion following Primary Human Immunodeficiency Virus Type 1 Infection—Evidence for Highly Susceptible Human Hosts
  The Journal of Infectious Diseases, 1997
• Seroreversion in human immunodeficiency virus-exposed but uninfected infants
  The Pediatric Infectious Disease Journal, 1995
• HIV‐1 Causing AIDS and Death in a Seronegative Individual
  Vox Sanguinis, 1994
• Seroreversion in Patients with End‐Stage HIV Infection
  Vox Sanguinis, 1994
• TRANSIENT SEROREVERSION IN CHILDREN BORN TO HUMAN IMMUNODEFICIENCY VIRUS 1-INFECTED MOTHERS
  The Pediatric Infectious Disease Journal, 1992